TTM
−$106.00K
YoY change
—
5Y CAGR
—
Peak year (2019)
$0.00
Cumulative gross profit
−$135.00K
Gross Profit history chart for Climb Bio (CLYM) from 2019 to 2025
Latest: −$97.00K
Gross Profit history table for Climb Bio (CLYM) from 2019 to 2025
| 2025 | −$97.00K | — | −$97.00K | ||
| 2024 | $0.00 | — | $0.00 | ||
| 2023 | $0.00 | — | $0.00 | ||
| 2022 | $0.00 | — | $0.00 | ||
| 2021 | $0.00 | — | $0.00 | ||
| 2020 | $0.00 | — | $0.00 | ||
| 2019 | $0.00 | — | — |
- 2025−$97.00K—
- 2024$0.00—
- 2023$0.00—
- 2022$0.00—
- 2021$0.00—
- 2020$0.00—
- 2019$0.00—
Gross Profit values are taken from Climb Bio's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Climb Bio (CLYM)
According to Climb Bio's latest reported financial statements, the company's current gross profit (TTM) is −$106.00K. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Climb Bio (CLYM) gross profit is −$97.00K.
Across the available history, gross profit reached its high of $0.00 in 2019 and its low of −$97.00K in 2025.
Climb Bio Gross Profit by Year
Climb Bio Gross Profit 2025: −$97.00K
Climb Bio gross profit in 2025 was −$97.00K.
Climb Bio Gross Profit 2024: $0.00
Climb Bio gross profit in 2024 was $0.00.
Climb Bio Gross Profit 2023: $0.00
Climb Bio gross profit in 2023 was $0.00.
Climb Bio Gross Profit 2022: $0.00
Climb Bio gross profit in 2022 was $0.00.
Climb Bio Gross Profit 2021: $0.00
Climb Bio gross profit in 2021 was $0.00.
See more financial history for Climb Bio (CLYM).
Sector peers by Gross Profit
Healthcare peers of Climb Bio (CLYM), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
Climb Bio (CLYM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation